BioArctic AB (BioArctic AB) Ending Cash Position : $47.16 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is BioArctic AB Ending Cash Position?

BioArctic AB's Ending Cash Position for the quarter that ended in Mar. 2024 was $47.16 Mil.

BioArctic AB's quarterly Ending Cash Position declined from Sep. 2023 ($62.95 Mil) to Dec. 2023 ($59.62 Mil) and declined from Dec. 2023 ($59.62 Mil) to Mar. 2024 ($47.16 Mil).

BioArctic AB's annual Ending Cash Position declined from Dec. 2021 ($93.34 Mil) to Dec. 2022 ($77.61 Mil) and declined from Dec. 2022 ($77.61 Mil) to Dec. 2023 ($59.62 Mil).

BioArctic AB Ending Cash Position Historical Data

The historical data trend for BioArctic AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB Ending Cash Position Chart

BioArctic AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

117.97

119.57

93.34

77.61

59.62

BioArctic AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															105.57	96.77	62.95	59.62	47.16

BioArctic AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

BioArctic AB's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	78.516	+	-18.895
	=	59.62

BioArctic AB's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	58.741	+	-11.578
	=	47.16

BioArctic AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of BioArctic AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

BioArctic AB (BioArctic AB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (OTCPK:BRCTF) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

BIOA B:Sweden 0RV2:UK B9A:Germany

Address

Warfvinges vag 35, Stockholm, SWE, SE-112 51

Website

https://www.bioarctic.se

BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.